In vitro mitochondrial failure and oxidative stress mimic biochemical features of Alzheimer disease

Neurochemistry International

Volumn 63, Issue 2, 2013, Pages 112-120

  Selvatici, Rita ^a   Marani, Luca ^a   Marino, Silvia ^a   Siniscalchi, Anna ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

BACE1; GSK3; Hydrogen peroxide; P35 25; Sodium azide; Tau

Indexed keywords

ACETYLCHOLINE; ASCORBIC ACID; BETA SECRETASE 1; CHOLINE; DEXTRO ASPARTIC ACID; GLUTAMIC ACID; GLUTATHIONE; MEMANTINE; PROTEIN P25; PROTEIN P35; TAU PROTEIN; TROLOX C;

ACETYLCHOLINE RELEASE; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SLICE; CELL METABOLISM; CHOLINERGIC NERVE CELL; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTROSTIMULATION; MALE; MITOCHONDRION; NERVE CELL CULTURE; NERVE DEGENERATION; NEUROSECRETION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

RATTUS;

EID: 84884863547     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.05.005     Document Type: Article

References (62)

1. Augustinack, J.C., Schneider, A., Mandelkow, E.M., Hyman, B.T., 2002. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol. 103, 26-35. (Pubitemid 36075309)
2. Badini, I., Beani, L., Bianchi, C., Marzola, G., Siniscalchi, A., 1997. Post-ischemic recovery of acetylcholine release in vitro: influence of different excitatory amino acid receptor subtype antagonists. Neurochem. Int. 31, 817-824. (Pubitemid 27493970)
3. Berndt, J.D., Callaway, N.L., Gonzalez-Lima, F., 2001. Effects of chronic sodium azide on brain and muscle cytochrome oxidase activity: a potential model to investigate environmental contributions to neurodegenerative diseases. J. Toxicol. Environ. Health 63, 67-77. (Pubitemid 32391857)
4. Bianchi, C., Marani, L., Marino, S., Barbieri, M., Nazzaro, C., Beani, L., Siniscalchi, A., 2007. Serotonin modulation of cell excitability and of [3H]GABA and [3H]-Daspartate efflux in primary cultures of rat cortical neurons. Neuropharmacology 52, 995-1002. (Pubitemid 46227489)
5. Biernat, J., Gustke, N., Drewes, G., Mandelkow, E.M., Mandelkow, E., 1993. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron 11, 153-163. (Pubitemid 23222542)
6. Blass, J.P., Baker, A.C., Ko, L., Black, R.S., 1990. Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation. Arch. Neurol. 47 (8), 864-869. (Pubitemid 20251716)
7. Bramblett, G.T., Goedert, M., Jakes, R., Merrick, S.E., Trojanowski, J.Q., Lee, V.M., 1993. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10 (6), 1089-1099. (Pubitemid 23194399)
8. Brittain, M.K., Brustovetsky, T., Sheets, P.L., Brittain, J.M., Khanna, R., Cummins, T.R., Brustovetsky, N., 2012. Delayed calcium dysregulation in neurons requires both the NMDA receptor and the reverse Na+/Ca2+ exchanger. Neurobiol. Dis. 46 (1), 109-117.
9. Callaway, N.L., Riha, P.D., Wrubel, K.M., McCollum, D., Gonzalez-Lima, F., 2002. Methylene blue restores spatial memory retention impaired by an inhibitor of cytochrome oxidase in rats. Neurosci. Lett. 332 (2), 83-86. (Pubitemid 35217846)
10. Castellani, R., Hirai, K., Aliev, G., Drew, K.L., Nunomura, A., Takeda, A., Cash, A.D., Obrenovich, M.E., Perry, G., Smith, M.A., 2002. Role of mitochondrial dysfunction in Alzheimer's disease. J. Neurosci. Res. 70 (3), 357-360. (Pubitemid 35222373)
11. Cavallini, S., Marino, S., Beani, L., Bianchi, C., Siniscalchi, A., 2003. Nociceptin inhibition of acetylcholine efflux from different brain areas. Neuroreport 14 (17), 2167-2170.
12. Cavallini, S., Marti, M., Marino, S., Selvatici, R., Beani, L., Bianchi, C., Siniscalchi, A., 2005. Effects of chemical ischemia in cerebral cortex slices. Focus on nitric oxide. Neurochem. Int. 47 (7), 482-490. (Pubitemid 41266878)
13. Choi, D.W., 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634.
14. Chung, S.H., 2009. Aberrant phosphorylation in the pathogenesis of Alzheimer's disease. BMB Rep. 2 (8), 467-474.
15. Cottrell, D.A., Borthwick, G.M., Johnson, M.A., Ince, P.G., Turnbull, D.M., 2002. The role of cytochrome c oxidase deficient hippocampal neurones in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 28, 390-396. (Pubitemid 35279072)
16. Craig, L.A., Hong, N.S., McDonald, R.J., 2011. Revisiting the cholinergic hypothesis in the development of Alzheimer's disease. Neurosci. Biobehav. Rev. 35, 1397-1409.
17. Crews, L., Masliah, E., 2010. Molecular mechanisms of neurodegeneration in Alzheimer's disease. Hum. Mol. Genet. 19 (R1), R12-R20.
18. Cruz, J.C., Kim, D., Moy, L.Y., Dobbin, M.M., Sun, X., Bronson, R.T., Tsai, L.H., 2006. P25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo. J. Neurosci. 26 (41), 10536-10541. (Pubitemid 44564604)
19. Duranteau, J., Chandel, N.S., Kulisz, A., Shao, Z., Schumacker, P.T., 1998. Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J. Biol. Chem. 273, 11619-11624. (Pubitemid 28272061)
20. Evans, D.B., Rank, K.B., Bhattacharya, K., Thomsen, D.R., Gurney, M.E., Sharma, S.K., 2000. Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase II inhibits tau's ability to promote microtubule assembly. J. Biol. Chem. 275 (32), 24977-24983. (Pubitemid 30626606)
21. Gabuzda, D., Busciglio, J., Chen, L.B., Matsudaira, P., Yankner, B.A., 1994. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J. Biol. Chem. 269 (18), 13623- 13628. (Pubitemid 24206141)
22. Gao, J., Zhu, Z.R., Ding, H.Q., Qian, Z., Zhu, L., Ke, Y., 2007. Vulnerability of neurons with mitochondrial dysfunction to oxidative stress is associated with downregulation of thioredoxin. Neurochem. Int. 50, 379-385. (Pubitemid 46110920)
23. Giordano, G., Costa, L.G., 2011. Primary neurons in culture and neuronal cell lines for in vitro neurotoxicological studies. Methods Mol. Biol. 758, 13-27.
24. Gu, Z., Nakamura, T., Lipton, S.A., 2010. Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases. Mol. Neurobiol. 41 (2-3), 55-72.
25. Hindle, J.V., 2010. Ageing, neurodegeneration and Parkinson's disease. Age Ageing 39 (2), 156-161.
26. Hooper, C., Killick, R., Lovestone, S., 2008. The GSK3 hypothesis of Alzheimer's disease. J. Neurochem. 104 (6), 1433-1439. (Pubitemid 351316776)
27. Iida, Y., Aoki, K., Asakura, T., Ueda, K., Yanaihara, N., Takakura, S., Yamada, K., Okamoto, A., Tanaka, T., Ohkawa, K., 2012. Hypoxia promotes glycogen synthesis and accumulation in human ovarian clear cell carcinoma. Int. J. Oncol. 40 (6), 2122-2130.
28. Iqbal, K., Grundke-Iqbal, I., 2005. Metabolic/signal transduction hypothesis of Alzheimer's disease and other tauopathies. Acta Neuropathol. 109 (1), 25-31. (Pubitemid 40287787)
29. Jope, R.S., Johnson, G.V., 2004. The glamour and gloom of glycogen synthase kinase- 3. Trends Biochem. Sci. 29 (2), 95-102. (Pubitemid 38186580)
30. Kish, S.J., Mastrogiacomo, F., Guttman, M., Furukawa, Y., Taanman, J.W., Dozić, S., Pandolfo, M., Lamarche, J., DiStefano, L., Chang, L.J., 1999. Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer's disease and in hereditary spinocerebellar ataxia disorders: a nonspecific change? J. Neurochem. 72 (2), 700-707. (Pubitemid 29055233)
31. Lau, A., Tymianski, M., 2010. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch. - Eur. J. Physiol. 460, 525-542.
32. Lauckner, J., Frey, P., Geula, C., 2003. Comparative distribution of tau phosphorylated at Ser262 in pre-tangles and tangles. Neurobiol. Aging 24 (6), 767-776. (Pubitemid 37303986)
33. Lee, S.H., Kim, K.R., Ryu, S.Y., Son, S., Hong, H.S., Mook-Jung, I., Lee, S.H., Ho, W.K., 2012. Impaired short-term plasticity in mossy fiber Synapses caused by mitochondrial dysfunction of dentate granule cells is the earliest synaptic deficit in a mouse model of Alzheimer's disease. J. Neurosci. 32 (17), 5953-5963.
34. LePage, K.T., Dickey, R.W., Gerwick, W.H., Jester, E.L., Murray, T.F., 2005. On the use of neuro-2a neuroblastoma cells versus intact neurons in primary culture for neurotoxicity studies. Crit. Rev. Neurobiol. 17 (1), 27-50.
35. Lin, M.T., Beal, M.F., 2006. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443 (7113), 787-795. (Pubitemid 44622683)
36. Lovell, M.A., Markesbery, W.R., 2007. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res. 35 (22), 7497-7504.
37. Marino, S., Marani, L., Nazzaro, C., Beani, L., Siniscalchi, A., 2007. Mechanisms of sodium azide-induced changes in intracellular calcium concentration in rat primary cortical neurons. Neurotoxicology 8 (3), 622-629. (Pubitemid 46843237)
38. Müller, W.E., Eckert, A., Kurz, C., Eckert, G.P., Leuner, K., 2010. Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease - therapeutic aspects. Mol. Neurobiol. 41, 159-171.
39. Nakamura, T., Cho, D.H., Lipton, S.A., 2012. Redox regulation of protein misfolding, mitochondrial dysfunction, synaptic damage, and cell death in neurodegenerative diseases. Exp. Neurol. 23, 812-821.
40. Noble, W., Olm, V., Takata, K., Casey, E., Mary, O., Meyerson, J., Gaynor, K., LaFrancois, J., Wang, L., Kondo, T., Davies, P., Burns, M., Veeranna, Nixon, R., Dickson, D., Matsuoka, Y., Ahlijanian, M., Lau, L.F., Duff, K., 2003. Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38 (4), 555-565. (Pubitemid 36645031)
41. Patrick, G.N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., Tsai, L.H., 1999. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402 (6762), 615-622. (Pubitemid 129516324)
42. Peineau, S., Bradley, C., Taghibiglou, C., Doherty, A., Bortolotto, Z.A., Wang, Y.T., Collingridge, G.L., 2008. The role of GSK-3 in synaptic plasticity. Br. J. Pharmacol. 153 (Suppl. 1), S428-S437. (Pubitemid 351341021)
43. Petrozzi, L., Ricci, G., Giglioli, N.J., Siciliano, G., Mancuso, M., 2007. Mitochondria and Neurodegeneration. Biosci. Rep. 27, 87-104. (Pubitemid 46940938)
44. Phillis, J.W., O'Regan, M.H., 2003. Characterization of modes of release of amino acids in the ischemic/reperfused rat cerebral cortex. Neurochem. Int. 43 (4-5), 461-467. (Pubitemid 36561300)
45. Pickrell, A.M., Fukui, H., Moraes, C.T., 2009. The role of cytochrome c oxidase deficiency in ROS and amyloid plaque formation. J. Bioenerg. Biomembr. 41, 453-456.
46. Praticò, D., Uryu, K., Leight, S., Trojanoswki, J.Q., Lee, V.M., 2001. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21 (12), 4183-4187. (Pubitemid 32538543)
47. Reddy, P.H., 2008. Mitochondrial medicine for aging and neurodegenerative diseases. Neuromol. Med. 10, 291-315.
48. Sadleir, K.R., Vassar, R., 2012. Cdk5 protein inhibition and Ab42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism: implications of CDK5 as a therapeutic target for Alzheimer disease. J. Biol. Chem. 287 (10), 7224-7235.
49. Schliebs, R., Arendt, T., 2011. The cholinergic system in aging and neuronal degeneration. Behav. Brain Res. 221 (2), 555-563.
50. Selvatici, R., Falzarano, S., Franceschetti, L., Cavallini, S., Marino, S., Siniscalchi, A., 2006. Differential activation of protein kinase C isoforms following chemical ischemia in rat cerebral cortex slices. Neurochem. Int. 49 (8), 729-736. (Pubitemid 44648490)
51. Selvatici, R., Previati, M., Marino, S., Marani, L., Falzarano, S., Lanzoni, I., Siniscalchi, A., 2009. Sodium azide induced neuronal damage in vitro: evidence for nonapoptotic cell death. Neurochem. Res. 34 (5), 909-916.
52. Siniscalchi, A., Cavallini, S., Marino, S., Falzarano, S., Franceschetti, L., Selvatici, R., 2006. Effects of chemical ischemia on cerebral cortex slices: focus on mitogenactivated protein kinase cascade. Ann. N. Y. Acad. Sci. 1090, 445-454. (Pubitemid 47092149)
53. Sotty, F., Danik, M., Manseau, F., Laplante, F., Quirion, R., Williams, S., 2003. Glutamatergic, cholinergic and GABAergic neurons contribute to the septohippocampal pathways and exhibit distinct electro-physiological properties: novel implications for hippocampal rhythmicity. J. Physiol. 551, 927-943. (Pubitemid 37221084)
54. Stockert, J.C., Blázquez-Castro, A., Cañete, M., Horobin, R.W., Villanueva, A., 2012. MTT assay for cell viability: intracellular localization of the formazan product is in lipid droplets. Acta Histochem. 114 (8), 785-796.
55. Swerdlow, R.H., 2012. Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease. Antioxid. Redox Signal. 16 (12), 1434-1455.
56. van Meerloo, J., Kaspers, G.J., Cloos, J., 2011. Cell sensitivity assays: the MTT assay. Methods Mol. Biol. 731, 237-245.
57. Vergun, O., Sobolevsky, A.I., Yelshansky, M.V., Keelan, J., Khodorov, B.I., Duchen, M.R., 2001. Exploration of the role of reactive oxygen species in glutamate neurotoxicity in rat hippocampal neurones in culture. J. Physiol. 531 (Pt 1), 147-163. (Pubitemid 32178033)
58. Vingtdeux, V., Davies, P., Dickson, D.W., Marambaud, P., 2011. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies. Acta Neuropathol. 121 (3), 337-349.
59. Wang, Y., Qin, Z.H., 2010. Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis 15, 1382-1402.
60. Wang, J.Z., Xia, Y.Y., Grundke-Iqbal, I., Iqbal, K., 2013. Abnormal hyperphosphorylation of Tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. J. Alzheimers Dis. 33 (Suppl. 1), S123-S139.
61. Wen, Y., Yu, W.H., Maloney, B., Bailey, J., Ma, J., Marié, I., Maurin, T., Wang, L., Figueroa, H., Herman, M., Krishnamurthy, P., Liu, L., Planel, E., Lau, L.F., Lahiri, D.K., Duff, K., 2008. Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron 57 (5), 680-690. (Pubitemid 351335351)
62. Zou, K., Gong, J.S., Yanagisawa, K., Michikawa, M., 2002. A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage. J. Neurosci. 22 (12), 4833-4841. (Pubitemid 37465598)